The UroLift® system for benign prostate hyperplasia

Written by: Mr Rono Mukherjee
Published: | Updated: 04/08/2021
Edited by: Kalum Alleyne

Benign prostate hyperplasia is a common issue for men over 50, which causes urination problems. Although this condition isn’t a type of cancer and doesn’t seriously threaten your health, it can cause embarrassment, discomfort and inconvenience. Mr Rono Mukherjee, a vastly experienced urological surgeon, outlines the best treatment option for this condition.


A man at peace with his prostate


The Covid-19 pandemic has, unfortunately, had a profound effect on the NHS benign urology service, causing longer waits for benign prostate hyperplasia (BPH) treatment, which can lead to worsening of symptoms. Without treatment, these symptoms can develop into acute urinary retention, leading to long-term bladder function difficulties.


Common BPH Symptoms:

The most common symptoms of benign prostate hyperplasia are related to the urination process. They include:

  • needing to urinate more frequently than usual
  • being woken up by the need to urinate during the night (nocturia)
  • urgency
  • hesitancy
  • weak flow
  • inability to urinate



If you are experiencing BPH symptoms and feel that the medication you’ve been prescribed isn’t producing the desired relief, I offer complete prostate assessment and treatment advice including TURP.


Since 2015 I have also been offering another treatment option, the UroLift® System. This is a minimally invasive and relatively simple procedure, which provides similar quality of life improvements to TURP treatment. My patients have reported extremely positive, long-lasting outcomes from this treatment.


The UroLift®​ System

UroLift® treatment has been approved by the National Institute for Healthcare and Excellence (NICE). It unblocks the prostate without the need for cutting, heating, or removing the problematic tissue, allowing patients to quickly return to their normal life. It is a procedure with minimal risk, which can be performed under local or general anaesthetic. The other advantages of this procedure include:

  • 15-20 minute day case procedure
  • rapid symptom relief and recovery
  • low-risk procedure - does not cause new erectile or ejaculatory dysfunction to patients
  • very few patients require post-operative catheterisation


For more information about UroLift®​ or any other urological treatment, you can request an appointment with Mr Mukherjee by visiting his Top Doctors Profile.

By Mr Rono Mukherjee

Mr Rono Mukherjee is an experienced consultant urological surgeon based at the Spire Cheshire Hospital, who specialises in treating all common urological problems. This includes male urinary/prostatic symptoms such as Benign Prostate Hyperplasia or BPH, female incontinence and recurrent cystitis/UTIs in women, erectile dysfunction, kidney stones, as well as common penile and scrotal problems.

He is skilled at performing all common urological procedures, penile and scrotal surgery, surgery for BPH including TURP and the renowned minimally invasive UroLift procedure. He is also specialised in minimally invasive surgery to large kidney stones. 

Mr Mukherjee also specialises in the diagnosis of important urological cancers including prostate cancer/raised PSA, haematuria, bladder cancer, testicular cancer, and kidney cancers.

A graduate of the University of Glasgow, Mr Mukherjee completed his basic surgical training on the West of Scotland Training rotation, completing his MD thesis in 2005 at Glasgow Royal Infirmary. His higher surgical training was done in Manchester, after which he became a consultant in Blackpool, before moving to Mid Cheshire Hospitals.

He held the position of Clinical Director for Urology at Mid Cheshire Hospitals NHS Foundation Trust between 2012 and 2020, as well as was the urology lead on the BMI South Cheshire Private Hospital Medical Advisory Committee, and is the Director of Urology Cheshire Ltd.

Aside from his practice, Mr Mukherjee is dedicated to both research, having published and presented at a national and international level in the field of urology, and to teaching and training. He is responsible for supervising a number of trainee doctors and currently serves as the Regional Training Programme Director for Urological Surgery in Mersey and Cheshire, and is the chair of the Regional Specialty Training and Education Committee in Urology (STEC).

He was appointed onto the Specialist Advisory Committee (SAC) in Urology in 2021, and is a member of the interview panel for National Selection of Specialty Trainees. 

Mr Mukherjee has published and presented internationally in the field of urological research, and has been nominated for a number of prizes for his teaching and training roles.

View Profile

Overall assessment of their patients

This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.